Compare
Xometry, Inc. vs XBP Global Holdings, Inc. vs Nutex Health Inc. vs Icts International N V
| Latest fiscal year | Xometry, Inc. XMTR | XBP Global Holdings, Inc. XBPLast annual report: year ended 2024-12-31 | Nutex Health Inc. NUTX | Icts International N V ICTSF |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2024-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $686.63M | $872.69M | $875.26M | $534.38M |
| Revenue growth (YoY) | +25.9% | n/a | +82.4% | +10.6% |
| Gross margin | 39.1% | 21.6% | 50.8% | 11.2% |
| Operating margin | -6.6% | -12.1% | 31.5% | -3.3% |
| Net margin | -9.0% | -24.7% | 8.1% | -2.7% |
| Net income | -$61.75M | -$215.15M | $70.79M | -$14.35M |
| EPS (Diluted) | n/a | $0.41 | $10.48 | -$0.40 |
| Operating cash flow | $6.09M | $23.27M | $248.12M | -$30.99M |
| Free cash flow | -$24.09M | $16.97M | $245.60M | -$32.80M |
| Cash & equivalents | $15.00M | $11.63M | $185.57M | $16.89M |
| Total assets | $703.72M | $390.42M | $918.52M | $165.55M |
| Total liabilities | $426.98M | $1.85B | $495.09M | $99.75M |
| Shareholders' equity | $276.74M | -$1.46B | $423.44M | -$21.23M |
| Return on year-end equity | -22.3% | n/a | 16.7% | n/a |
| Shares outstanding | n/a | 30.17M | 7.09M | 37.43M |
Revenue, most recent five fiscal years
| Fiscal year | Xometry, Inc. | XBP Global Holdings, Inc. | Nutex Health Inc. | Icts International N V |
|---|---|---|---|---|
| Latest | $686.63M Ended 2025-12-31 | $872.69M Ended 2024-12-31 | $875.26M Ended 2025-12-31 | $534.38M Ended 2025-12-31 |
| 1 year earlier | $545.53M Ended 2024-12-31 | n/a | $479.95M Ended 2024-12-31 | $483.31M Ended 2024-12-31 |
| 2 years earlier | $463.41M Ended 2023-12-31 | n/a | $247.65M Ended 2023-12-31 | $431.54M Ended 2023-12-31 |
| 3 years earlier | $380.92M Ended 2022-12-31 | n/a | $219.29M Ended 2022-12-31 | $324.98M Ended 2022-12-31 |
| 4 years earlier | $218.34M Ended 2021-12-31 | n/a | $331.53M Ended 2021-12-31 | $324.93M Ended 2021-12-31 |